Early diagnosis by mNGS could improve the prognosis for severe leptospirosis patients

Author:

Jiang# Xuqin1,Jiang# Hui2,Xiong# Yingying3,Fang# Ming4,Geng Bei5,Wu* Huimei6,Mei* Xiaodong7

Affiliation:

1. Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

2. Department of Pulmonary and Critical Care Medicine, Wanbei Coal and Power Group General Hospital, Suzhou, China

3. Department of Pediatrics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

4. Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Anhui University of Science and Technology, Huainan, China

5. The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

6. Department of Geriatric Respiratory and Critical Care, Anhui Geriatric Institute, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022.

7. Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

Abstract

Abstract PurposesTo evaluate the diagnostic efficiency of metagenomics next generation sequencing (mNGS) assay in severe leptospirosis and its role on prognosis. Methods We retrospectively reviewed the medical records of patients with confirmed leptospirosis from Jan. 1, 2019 to Dec. 31, 2021 from three hospitals. Detailed data including socio-demographic data, clinical manifestations, laboratory examination results, CT images etc. were collected and analyzed. Results Six severe cases were included in this study. All were diagnosed by positive mNGS results. Three of the patients were also polymerase chain reaction examined and presented negative results. Five patients were diagnosed by mNGS assay within two or three days and antibiotics were down-graded to ceftriaxone in them. All of them were cured finally. One case, who was diagnosed by mNGS late on day 5, died. Conclusions mNGS is highly efficient in diagnosing leptospirosis and could possibly reduce the mortality rate if used at an early stage.

Funder

National Natural Science Foundation of China

Publisher

Research Square Platform LLC

Reference26 articles.

1. Factors associated with severity and mortality in patients with confirmed leptospirosis at a regional hospital in northern Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi;Wang H,2020

2. Clinical presentations and predictors of mortality for leptospirosis - A study from suburban area in Malaysia;Fann R;The Medical journal of Malaysia,2020

3. Determinants of mortality and impact of therapy in patients with leptospirosis admitted for intensive care in a Sri Lankan hospital–a three year retrospective study;Weeratunga P;Pathogens and global health,2015

4. Severe leptospirosis in tropical Australia: Optimising intensive care unit management to reduce mortality;Smith S;PLoS Negl Trop Dis,2019

5. A first insight into the genomic diversity of Leptospira strains isolated from patients in Cuba;Noda A;PLoS One,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3